KEHREL BEATE has a total of 12 patent applications. Its first patent ever was published in 2000. It filed its patents most often in Germany, Australia and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are CBIO LTD, OAK CREST INST OF SCIENCE and CAROLUS THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Germany | 3 | |
#2 | Australia | 2 | |
#3 | United States | 2 | |
#4 | African Regional Industrial Property Organization | 1 | |
#5 | EPO (European Patent Office) | 1 | |
#6 | African Intellectual Property Organization | 1 | |
#7 | WIPO (World Intellectual Property Organization) | 1 | |
#8 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology | |
#4 | Measurement | |
#5 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Climate change adaptation technologies | |
#4 | Peptides | |
#5 | Enzymes | |
#6 | Analysing materials | |
#7 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Brodde Martin | 12 |
#2 | Kehrel Beate | 12 |
Publication | Filing date | Title |
---|---|---|
US2014044796A1 | Detection and removal of misfolded proteins/peptides | |
AU1503202A | Oxidized proteins, their biological activity, and therapeutic and diagnostic measures, which are derived from the active mechanism, from the use of these proteins or from the inhibition thereof | |
DE10148624A1 | Medicaments useful e.g. for preventing thrombosis, inhibiting transplant rejection or treating chronic inflammatory reactions comprises agents inhibiting binding of oxidized proteins to CD36, | |
DE10051983A1 | Medicaments useful e.g. for preventing thrombosis, inhibiting transplant rejection or treating chronic inflammatory reactions comprises agents inhibiting binding of oxidized proteins to CD36, | |
DE10045047A1 | Medicament containing activated antithrombin III |